Dr. Alex Cho, MD, MBA is an Assistant Professor of Medicine and a member of the DUHS Center for Personalized Medicine at Duke University. After receiving an AB in Chemistry from Harvard and his MD from the University of Minnesota, he completed a residency in internal medicine at NYU and Bellevue Hospital Center. He then came to Duke to complete a fellowship in general internal medicine and earn an MBA at Fuqua. His research studies the utility of incorporating testing for genomic variants associated with disease risk and drug response into primary care practice.
Dr. Cho directs the DUHS Innovation Development, Evaluation & Applications (IDEAs) group, a new group within the health system to promote the translation of care delivery innovations. Previously, he served as Special Assistant to Dr Victor Dzau, Chancellor for Health Affairs for Duke University, and President and CEO of the Duke University Health System. He is also the associate program director for ambulatory care for the Duke internal medicine residency program, and precepts at the Duke Outpatient Clinic.
Learn more about Dr. Cho's research in GenomeLIFE
Voils CI, Coffman CJ, Edelman D, Maciejewski ML, Grubber JM, Sadeghpour A, Cho A, McKenzie J, Blanpain F, Scheuner M, Sandelowski M, Gallagher MP, Ginsburg GS, Yancy WS, Trials. 2012 Aug 1;13(1):121. Abstract
Cho AH, Killeya-Jones LA, O'Daniel JM, Kawamoto K, Gallagher P, Haga S, Lucas JE, Trujillo GM, Joy SV, Ginsburg GS, BMC Health Serv Res. 2012;12:16. Abstract
Ackerly DC, Sangvai DG, Udayakumar K, Shah BR, Kalman NS, Cho AH, Schulman KA, Fulkerson WJ, Dzau VJ, Acad Med. 2011 May;86(5):575-9. Abstract
Haga SB, Carrig MM, O'Daniel JM, Orlando LA, Killeya-Jones LA, Ginsburg GS, Cho A, J Gen Intern Med. 2011 Aug;26(8):834-40. Abstract
Cho AH, Arar NH, Edelman DE, Hartwell PH, Oddone EZ, Yancy WS, Telemed J E Health. 2010 Jun;16(5):595-602. Abstract
© 2004-2013, Duke Institute for Genome Sciences & Policy. Duke University | Duke Medicine | Interdisciplinary Studies at Duke